e-learning
resources
Milan 2017
Monday, 11.09.2017
Innovative approaches to model human lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patient derived lung tissue cultures for drug identification and validation
M. Konigshoff (Denver, United States of America)
Source:
International Congress 2017 – Innovative approaches to model human lung diseases
Session:
Innovative approaches to model human lung diseases
Session type:
Hot topics
Number:
1936
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Konigshoff (Denver, United States of America). Patient derived lung tissue cultures for drug identification and validation. International Congress 2017 – Innovative approaches to model human lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Small cell lung cancer Xenografts can be successfully grafted from bronchoscopy derived samples: model for lung cancer translational research
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
PP214 – Human precision-cut lung slices generated from excess donor lungs as a model for IPF and drug screening
Source: ERS Lung Science Conference 2021
Year: 2021
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019
Expression of apoptotic markers in lung tissue of COPD patients: preliminary results
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018
Lung tissue engineering: making a functional human lung
Source: International Congress 2016 – Regeneratives approaches to COPD
Year: 2016
Human lung scaffolds to model lung disease and tissue regeneration
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
Methods of identification lung cancer stem cells: a pilot study.
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Oral presentation: Human lung parenchyma cells: a potential therapeutic cell source for lung disease
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021
Obtaining the right cell: primary cell cultures from tissue biopsies
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006
YI03 - Lung tissue engineering: generation and characterization of decellularized lung scaffolds for stem cell differentiation
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Bronchoscopic findings in lung cancer: diagnostic yield of specimen collection method compared to histological type
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005
CellCollector®: A novel method for the isolation of circulating tumor cells (CTC) in vivo and ex vivo in lung cancer patients during therapy
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept